FDA Recalls Sodium Chloride Injection Due to Incomplete Container Seals
B. Braun Medical's 0.9% Sodium Chloride Injection batches recalled due to risk of incomplete seals that could allow leakage, potentially compromising sterility. The recall affects 1,343,982 bags distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II sterility defect recall for intravenous injection with potential contamination risk if seals fail. No reported illnesses or injuries, fitting the 'risk-of-harm without reported injury' criterion for score 3.
Plain-English summary
B. Braun Medical Inc. is recalling 1,343,982 bags of 0.9% Sodium Chloride Injection, USP in Excel Plus IV containers. The affected lots have a manufacturing defect that may result in incomplete seals near the port assembly of the container.
An incomplete seal can allow microscopic channel leaks in the product. Because this is a sterile intravenous solution intended for injection directly into the bloodstream, any leakage risks contamination with non-sterile material. The FDA classified this as a Class II recall due to the lack of sterility assurance.
The recalled batches were distributed nationwide to hospitals, healthcare facilities, and other medical institutions. If you have received any of the affected lots, do not use the product. Contact B. Braun Medical Inc. or your supplier for replacement stock or return instructions.
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- B. Braun Medical Inc.
- Category
- Drug — Intravenous Injection
- Hazard
- sterility-defect
- container-leakage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lots: 0061786962 Exp. 11/30/2023
- 0061797767 Exp. 04/30/2024
- 0061797768 Exp. 05/31/2024
- 0061787769 Exp. 05/31/2024
- 0061797770 Exp. 05/31/2024
- 0061797771 Exp. 05/31/2024
- 0061797772 Exp. 05/31/2024
- 0061797773 Exp. 05/31/2024
- 0061797774 Exp. 05/31/2024
- 0061797775 Exp. 05/31/2024
- 0061797776 Exp. 05/31/2024
- 0061812946 Exp. 05/31/2024
- 0061812947 Exp. 05/31/2024
- 0061812948 Exp. 05/31/2024
- 0061812949 Exp. 05/31/2024
- 0061812950 Exp. 05/31/2024
- 0061816017 Exp. 06/30/2024
- 0061816018 Exp. 06/30/2024
- 0061816019 Exp. 06/30/2024
- 0061816020 Exp. 06/30/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SODIUM CHLORIDE
- SevereFDA Class I Recall: B. Braun Sodium Chloride Injection for Particulate Matter
FDA (Drugs) · 2024-08-28
- ModerateIntravenous Sodium Chloride Injection Recalled for Incomplete Labeling and Warnings
FDA (Drugs) · 2023-08-16
- HighSodium Chloride Injection Bags Recalled for Potential Leakage and Sterility Risk
FDA (Drugs) · 2023-07-19
- HighSodium Chloride Injection Recalled Due to Storage Temperature Exposure Risk
FDA (Drugs) · 2023-06-07
- HighSodium Chloride Injection Recalled for Incomplete Seal and Potential Leakage
FDA (Drugs) · 2023-03-01
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27